Results 231 to 240 of about 7,721,674 (406)
Self-rated health and mortality: a review of twenty-seven community studies.
E. Idler, Y. Benyamini
semanticscholar +1 more source
Objective There are no US Food and Drug Administration–approved therapies for Raynaud phenomenon (RP) in the United States. Clinical trials have been challenged by study design. Important advances in RP patient‐reported outcome measures and mechanistic quantification allow RP‐related pain characterization.
Tracy M. Frech +4 more
wiley +1 more source
The overlapping impacts of heat and COVID-19 on mortality in Flanders, Belgium: a time-stratified case-crossover analysis. [PDF]
Ali EA +6 more
europepmc +1 more source
Objective This systematic review aimed to assess the diagnostic accuracy of algorithms used to identify rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) in electronic health records (EHRs). Methods We searched MEDLINE, Embase, and CENTRAL databases and included studies that validated case definitions against a reference standard such ...
Constanza Saka‐Herrán +10 more
wiley +1 more source
How does mortality compare between different countries/regions of birth for the population of England and Wales, 2007 to 2021? A descriptive, observational study. [PDF]
Hiam L, Minton J, Burns R, Aldridge RW.
europepmc +1 more source
Serum Lipids, Apolipoproteins, and Mortality among Coronary Artery Disease Patients [PDF]
Ding Ding +14 more
openalex +1 more source
Objectives Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). The study aimed to externally validate a genetic risk score (GRS) and a combined risk score for predicting the risk of RA‐associated PF in an independent cohort of early‐RA patients. Methods This study utilized an inception cohort of 1118 patients
Mikael Brink +3 more
wiley +1 more source
Maternal mortality in the Republic of Cyprus: Insights from population-based observations 2004-2022. [PDF]
Hadjigeorgiou E +6 more
europepmc +1 more source
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner +14 more
wiley +1 more source

